2,947 research outputs found
Genetic and biochemical analyses of chromosome and plasmid gene homologues encoding ICL and ArCP domains in Vibrioanguillarum strain 775
Anguibactin, the siderophore produced by Vibrio anguillarum 775 is synthesized from 2,3-dihydroxybenzoic acid (DHBA), cysteine and hydroxyhistamine via a nonribosomal peptide synthetase (NRPS) mechanism. Most of the genes encoding anguibactin biosynthetic proteins are harbored by the pJM1 plasmid. In this work we report the identification of a homologue of the plasmid-encoded angB on the chromosome of strain 775. The product of both genes harbor an isochorismate lyase (ICL) domain that converts isochorismic acid to 2,3-dihydro-2,3-dihydroxybenzoic acid, one of the steps of DHBA synthesis. We show in this work that both ICL domains are functional in the production of DHBA in V. anguillarum as well as in E. coli. Substitution by alanine of the aspartic acid residue in the active site of both ICL domains completely abolishes their isochorismate lyase activity in vivo. The two proteins also carry an aryl carrier protein (ArCP) domain. In contrast with the ICL domains only the plasmid encoded ArCP can participate in anguibactin production as determined by complementation analyses and site-directed mutagenesis in the active site of the plasmid encoded protein, S248A. The site-directed mutants, D37A in the ICL domain and S248A in the ArCP domain of the plasmid encoded AngB were also tested in vitro and clearly show the importance of each residue for the domain function and that each domain operates independently.
Loop-induced photon spectral lines from neutralino annihilation in the NMSSM
We have computed the loop-induced processes of neutralino annihilation into
two photons and, for the first time, into a photon and a Z boson in the
framework of the NMSSM. The photons produced from these radiative modes are
monochromatic and possess a clear "smoking gun" experimental signature. This
numerical analysis has been done with the help of the SloopS code, initially
developed for automatic one-loop calculation in the MSSM. We have computed the
rates for different benchmark points coming from SUGRA and GMSB soft SUSY
breaking scenarios and compared them with the MSSM. We comment on how this
signal can be enhanced, with respect to the MSSM, especially in the low mass
region of the neutralino. We also discuss the possibility of this observable to
constrain the NMSSM parameter space, taking into account the latest limits from
the FERMI collaboration on these two modes.Comment: 18 pages, 3 figures. Minor clarifications added in the text. Typing
mistakes and references corrected. Matches published versio
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
Epigenetics is the study of all mechanisms that regulate gene transcription and genome stability that are maintained throughout the cell division, but do not include the DNA sequence itself. The best-studied epigenetic mechanism to date is DNA methylation, where methyl groups are added to the cytosine base within cytosine–guanine dinucleotides (CpG sites). CpGs are frequently clustered in high density (CpG islands (CGIs)) at the promoter of over half of all genes. Current knowledge of transcriptional regulation by DNA methylation centres on its role at the promoter where unmethylated CGIs are present at most actively transcribed genes, whereas hypermethylation of the promoter results in gene repression. Over the last 5 years, research has gradually incorporated a broader understanding that methylation patterns across the gene (so-called intragenic or gene body methylation) may have a role in transcriptional regulation and efficiency. Numerous genome-wide DNA methylation profiling studies now support this notion, although whether DNA methylation patterns are a cause or consequence of other regulatory mechanisms is not yet clear. This review will examine the evidence for the function of intragenic methylation in gene transcription, and discuss the significance of this in carcinogenesis and for the future use of therapies targeted against DNA methylation
Quantifying single nucleotide variant detection sensitivity in exome sequencing
BACKGROUND: The targeted capture and sequencing of genomic regions has rapidly demonstrated its utility in genetic studies. Inherent in this technology is considerable heterogeneity of target coverage and this is expected to systematically impact our sensitivity to detect genuine polymorphisms. To fully interpret the polymorphisms identified in a genetic study it is often essential to both detect polymorphisms and to understand where and with what probability real polymorphisms may have been missed. RESULTS: Using down-sampling of 30 deeply sequenced exomes and a set of gold-standard single nucleotide variant (SNV) genotype calls for each sample, we developed an empirical model relating the read depth at a polymorphic site to the probability of calling the correct genotype at that site. We find that measured sensitivity in SNV detection is substantially worse than that predicted from the naive expectation of sampling from a binomial. This calibrated model allows us to produce single nucleotide resolution SNV sensitivity estimates which can be merged to give summary sensitivity measures for any arbitrary partition of the target sequences (nucleotide, exon, gene, pathway, exome). These metrics are directly comparable between platforms and can be combined between samples to give “power estimates” for an entire study. We estimate a local read depth of 13X is required to detect the alleles and genotype of a heterozygous SNV 95% of the time, but only 3X for a homozygous SNV. At a mean on-target read depth of 20X, commonly used for rare disease exome sequencing studies, we predict 5–15% of heterozygous and 1–4% of homozygous SNVs in the targeted regions will be missed. CONCLUSIONS: Non-reference alleles in the heterozygote state have a high chance of being missed when commonly applied read coverage thresholds are used despite the widely held assumption that there is good polymorphism detection at these coverage levels. Such alleles are likely to be of functional importance in population based studies of rare diseases, somatic mutations in cancer and explaining the “missing heritability” of quantitative traits
Quantum Gravity in Everyday Life: General Relativity as an Effective Field Theory
This article is meant as a summary and introduction to the ideas of effective
field theory as applied to gravitational systems.
Contents:
1. Introduction
2. Effective Field Theories
3. Low-Energy Quantum Gravity
4. Explicit Quantum Calculations
5. ConclusionsComment: 56 pages, 2 figures, JHEP style, Invited review to appear in Living
Reviews of Relativit
Higgs boson decay into 2 photons in the type~II Seesaw Model
We study the two photon decay channel of the Standard Model-like component of
the CP-even Higgs bosons present in the type II Seesaw Model. The corresponding
cross-section is found to be significantly enhanced in parts of the parameter
space, due to the (doubly-)charged Higgs bosons' virtual
contributions, while all the other Higgs decay channels remain Standard
Model(SM)-like. In other parts of the parameter space (and
) interfere destructively, reducing the two photon branching ratio
tremendously below the SM prediction. Such properties allow to account for any
excess such as the one reported by ATLAS/CMS at GeV if confirmed
by future data; if not, for the fact that a SM-like Higgs exclusion in the
diphoton channel around 114-115 GeV as reported by ATLAS, does not contradict a
SM-like Higgs at LEP(!), and at any rate, for the fact that ATLAS/CMS exclusion
limits put stringent lower bounds on the mass, particularly in
the parameter space regions where the direct limits from same-sign leptonic
decays of do not apply.Comment: 26 pages, 7 figure
Probing the charged Higgs boson at the LHC in the CP-violating type-II 2HDM
We present a phenomenological study of a CP-violating two-Higgs-doublet Model
with type-II Yukawa couplings at the Large Hadron Collider (LHC). In the light
of recent LHC data, we focus on the parameter space that survives the current
and past experimental constraints as well as theoretical bounds on the model.
Once the phenomenological scenario is set, we analyse the scope of the LHC in
exploring this model through the discovery of a charged Higgs boson produced in
association with a W boson, with the former decaying into the lightest neutral
Higgs and a second W state, altogether yielding a b\bar b W^+W^- signature, of
which we exploit the W^+W^- semileptonic decays.Comment: 37 pages, 16 figures; v2 updated treatment of LHC constraint
Re-Assembly of the Genome of Francisella tularensis Subsp. holarctica OSU18
Francisella tularensis is a highly infectious human intracellular pathogen that is the causative agent of tularemia. It occurs in several major subtypes, including the live vaccine strain holarctica (type B). F. tularensis is classified as category A biodefense agent in part because a relatively small number of organisms can cause severe illness. Three complete genomes of subspecies holarctica have been sequenced and deposited in public archives, of which OSU18 was the first and the only strain for which a scientific publication has appeared [1]. We re-assembled the OSU18 strain using both de novo and comparative assembly techniques, and found that the published sequence has two large inversion mis-assemblies. We generated a corrected assembly of the entire genome along with detailed information on the placement of individual reads within the assembly. This assembly will provide a more accurate basis for future comparative studies of this pathogen
Feynman Rules for the Rational Part of the Standard Model One-loop Amplitudes in the 't Hooft-Veltman Scheme
We study Feynman rules for the rational part of the Standard Model
amplitudes at one-loop level in the 't Hooft-Veltman scheme.
Comparing our results for quantum chromodynamics and electroweak 1-loop
amplitudes with that obtained based on the Kreimer-Korner-Schilcher (KKS)
scheme, we find the latter result can be recovered when our
scheme becomes identical (by setting in our expressions)
with the KKS scheme. As an independent check, we also calculate Feynman rules
obtained in the KKS scheme, finding our results in complete agreement with
formulae presented in the literature. Our results, which are studied in two
different schemes, may be useful for clarifying the
problem in dimensional regularization. They are helpful to eliminate or find
ambiguities arising from different dimensional regularization schemes.Comment: Version published in JHEP, presentation improved, 41 pages, 10
figure
Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS.
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV). This protection was attributed to antibodies specific for cell proteins including human leucocyte antigens (HLA) class I and II incorporated into virions during vaccine and challenge virus preparation. We show here, using HLA bead arrays, that vaccinated macaques protected from virus challenge had higher serum antibody reactivity compared with non-protected animals. Moreover, reactivity was shown to be directed against HLA framework determinants. Previous studies failed to correlate serum antibody mediated virus neutralisation with protection and were confounded by cytotoxic effects. Using a virus entry assay based on TZM-bl cells we now report that, in the presence of complement, serum antibody titres that neutralise virus infectivity were higher in protected animals. We propose that complement-augmented virus neutralisation is a key factor in inducing sterilising immunity and may be difficult to achieve with HIV/SIV Env-based vaccines. Understanding how to overcome the apparent block of inactivated SIV vaccines to elicit anti-envelope protein antibodies that effectively engage the complement system could enable novel anti-HIV antibody vaccines that induce potent, virolytic serological response to be developed
- …